UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000008864
Receipt No. R000010388
Public title The study of effect of gentian violet in chronic prurigo.
Date of disclosure of the study information 2012/09/10
Last modified on 2019/03/13 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The study of effect of gentian violet in chronic prurigo.
Acronym The study of effect of gentian violet in chronic prurigo.
Scientific Title The study of effect of gentian violet in chronic prurigo.
Scientific Title:Acronym The study of effect of gentian violet in chronic prurigo.
Region
Japan

Condition
Condition chronic prurigo
Classification by specialty
Dermatology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The study of effect of gentian violet in chronic prurigo
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes assessment of skin eruption based on photography
VAS scale
Behavioral rating scale
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 application of gentian violet
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria The patients of chronic prurigo who are relative good general condition, able to apply gentian violet by themselves, able to assess the degree of pruritus, and with imformed consent.
Key exclusion criteria The patients without severe liver dysfunction, undergoing artificial dialysis, allergy for gentian violet, nor being breast-feeding.
Target sample size 30

Research contact person
Last name of lead principal investigator
1st name Sestuya
Middle name
Last name Aiba
Organization Tohoku University School of medicine
Division name Department of dermatology
Zip code 980-8574
Address Seiryo-chou 1-1, aoba-ku, Sendai, Miyagi, Japan
TEL 022(717)-7271
Email saiba@med.tohoku.ac.jp

Public contact
1st name of contact person
1st name Hiromi
Middle name
Last name Suzuki
Organization Tohoku University School of medicine
Division name Department of Dermatology
Zip code 980-8574
Address Seiryo-chou 1-1, aoba-ku, Sendai, Miyagi, Japan
TEL 022(717)-7271
Homepage URL
Email hrmsuzuki@yahoo.co.jp

Sponsor
Institute Department of Dermatology
Institute
Department

Funding Source
Organization donation from companies.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Tohoku Univ. Hospital Clinical research Ethics Committee
Address Seiryo-chou 1-1, aoba-ku, Sendai, Miyagi, Japan
Tel 022(717)7000
Email protocol-support@trc.med.tohoku.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2012 Year 09 Month 10 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2012 Year 09 Month 04 Day
Date of IRB
Anticipated trial start date
2012 Year 09 Month 10 Day
Last follow-up date
2013 Year 08 Month 31 Day
Date of closure to data entry
2013 Year 09 Month 30 Day
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2012 Year 09 Month 06 Day
Last modified on
2019 Year 03 Month 13 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000010388